Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner

Journal Article · · J. Med. Chem.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
DOE - Office Of Science; NIH; UNIVERSITY
OSTI ID:
1901249
Journal Information:
J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (18) Vol. 65
Country of Publication:
United States
Language:
ENGLISH

References (33)

Chemical Biology of Protein N‐Terminal Methyltransferases journal February 2019
α-amino trimethylation of CENP-A by NRMT is required for full recruitment of the centromere journal March 2017
Process Development of a GCS Inhibitor Including Demonstration of Lossen Rearrangement on Kilogram Scale journal April 2015
Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease journal March 2018
NRMT is an α-N-methyltransferase that methylates RCC1 and retinoblastoma protein journal August 2010
Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis journal March 2015
Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease journal January 2015
Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1 journal February 2022
N-terminal α-methylation of RCC1 is necessary for stable chromatin association and normal mitosis journal April 2007
Occurrence of methylated amino acids as N-termini of proteins from Escherichia coli ribosomes journal April 1977
Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1 journal March 2021
N-degron and C-degron pathways of protein degradation journal January 2019
A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Syndrome and Acute Myeloid Leukemia journal November 2019
Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies journal July 2020
Kinetic Mechanism of Protein N-terminal Methyltransferase 1 journal May 2015
Venglustat in adult Gaucher disease type 3: Preliminary safety, pharmacology, and exploratory efficacy from a phase 2 trial in combination with imiglucerase (LEAP) journal February 2019
Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development journal October 2021
Genetics and Therapies for GM2 Gangliosidosis journal May 2018
Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation journal February 2019
Protein Methyltransferases: A Distinct, Diverse, and Dynamic Family of Enzymes journal December 2015
The role of tazemetostat in relapsed/refractory follicular lymphoma journal January 2021
α-N-Methylation of Damaged DNA-binding Protein 2 (DDB2) and Its Function in Nucleotide Excision Repair journal June 2014
Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors journal January 2015
An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2 journal November 2018
Facile synthesis of SAM–peptide conjugates through alkyl linkers targeting protein N-terminal methyltransferase 1 journal January 2016
A direct, ratiometric, and quantitative MALDI–MS assay for protein methyltransferases and acetyltransferases journal June 2015
Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors journal June 2020
A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics journal December 2005
Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases journal March 2016
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease journal June 2016
Methyltransferase-like protein 11A promotes migration of cervical cancer cells via up-regulating ELK3 journal October 2021
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
  • Peterschmitt, M. Judith; Crawford, Nigel P. S.; Gaemers, Sebastiaan J. M.
  • Clinical Pharmacology in Drug Development, Vol. 10, Issue 1 https://doi.org/10.1002/cpdd.865
journal August 2020
Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues journal July 2020

Similar Records

Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1
Journal Article · 2019 · Journal of Medicinal Chemistry · OSTI ID:1604173

Structural basis for substrate recognition by the human N-terminal methyltransferase 1
Journal Article · 2015 · Genes & Development · OSTI ID:1236265

Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrat
Journal Article · 2020 · J. Med. Chem. · OSTI ID:1833645

Related Subjects